COMPOSITION
Xylaxin injection (2% Solution) contains Xylazine Hydrochloride 23.22 mg per ml.
INDICATIONS
Xylaxin injection is recommended for inducing sedation and analgesia in various animals, for restraining of animals for routine observations, minor surgical interventions, immobilization of animals during transportation and transhipment or any similar functions. It can also be used as a preanaesthetic to general anaesthesia.
| ADMINISTRATION
By intramuscular route. For horses intravenous.
|
CONTRA-INDIACATIONS
Xylaxin should not be used in conjunction with tranquilizers or neuroleptic drugs. Animals in the last term of pregnancy should not be given the drug as it may induce early parturition or abortion. Cats and dogs with oesophageal obstruction, intestinal torsion or hernia as well as animals with pulmonary disorders should not be injected with Xylaxin.
PRECAUTIONS
After administration of Xylaxin the animal should be left undisturbed as excitement may reduce the level of sedation. Accidental falls and injury to be avoided during the induction of sedation by keeping the animal under observation after the onset of sedation. Caution is required while administering the drug in weak and debilitated animals.
SIDE EFFECTS
Xylaxin is well tolerated in most animals without any side effects. A brief rise in blood pressure may occur which gradually becomes normal. Sweating and urination in horses, liquid and soft faeces in cattle, emesis in cats and dogs are some of the effects. The drug is rapidly excreted from the body.
ANTIDOTE
Yohimbine hydrochloride and 4-amino pyridine are the antidotes for Xylaxin.
